ANTIBODY PRE-LOADED CD16+NK-92 CELLS AS AN EFFECTIVE THERAPEUTIC PRODUCT FOR TUMOR LYSIS

阅读量:

26

申请(专利)号:

EP20200847556

申请日期:

2020-07-27

公开/公告号:

EP4003376A1

公开/公告日期:

2022-06-01

申请(专利权)人:

NANTKWEST, INC.

发明人:

BJ SimonM SaxenaR AliJ Thibault

展开

摘要:

Provided herein are pharmaceutical compositions, comprising a pharmaceutically acceptable carrier and therapeutically effective amounts of high affinity Natural Killer (haNK) cells and a therapeutic antibody in the form of a combined preparation. Also provided herein are methods for treating cancer by using the pharmaceutical composition comprising the haNK cells and the therapeutic antibody.

展开

通过文献互助平台发起求助,成功后即可免费获取论文全文。

相似文献

参考文献

引证文献

站内活动

辅助模式

0

引用

文献可以批量引用啦~
欢迎点我试用!

引用